Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
president trump
6
×
raleigh-durham blog main
raleigh-durham top stories
6
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
medicare
pfizer
cancer
cancer immunotherapy
investing
novartis
roche
startups
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
What
drug
6
×
roundup
bio
prices
today
alzheimer’s
annual
attention
biotech
patients
pharmaceutical
plan
acquisitions
advantages
ahead
albert
ambien
american
asco
assessed
attendees
away
bar
biggest
bourla
bringing
brings
camp’s
cancer
cash
ceo
ceos
chicago
city
clinical
combinations
communities
community’s
companies
company
Language
unknown
unset
Current search:
drug
×
" president trump "
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More